Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-05 Sale |
2023-06-07 4:11 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,536 | $2.2404 | $7,922 | 809,278 (Direct) |
View |
| 2023-06-02 Sale |
2023-06-05 4:10 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
631 | $2.22 | $1,401 | 244,730 (Direct) |
View |
| 2023-05-04 Sale |
2023-05-05 5:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,805 | $3.3516 | $12,753 | 812,814 (Direct) |
View |
| 2023-04-20 Sale |
2023-04-24 6:09 pm |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
6,770 | $4.0496 | $27,416 | 158,230 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-05 5:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,497 | $3.97 | $13,883 | 816,619 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-07 4:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,506 | $3.16 | $11,079 | 820,116 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:36 pm |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
6,357 | $3.0292 | $19,257 | 128,313 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:35 pm |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
6,878 | $3.0292 | $20,835 | 146,122 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:33 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
11,239 | $3.0292 | $34,045 | 210,687 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:30 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
11,205 | $3.0292 | $33,942 | 245,361 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:28 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
33,033 | $3.0292 | $100,064 | 823,622 (Direct) |
View |
| 2023-02-27 Sale |
2023-03-01 4:05 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
2,802 | $3.0368 | $8,509 | 161,566 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 4:07 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,869 | $3.1891 | $18,717 | 64,131 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:11 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
4,141 | $3.4 | $14,079 | 164,368 (Direct) |
View |
| 2023-02-06 Sale |
2023-02-08 4:09 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,950 | $3.4 | $13,430 | 604,655 (Direct) |
View |
| 2023-01-04 Sale |
2023-01-05 6:16 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,922 | $3.27 | $12,825 | 608,605 (Direct) |
View |
| 2022-12-05 Sale |
2022-12-06 5:00 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,490 | $5.17 | $18,043 | 612,527 (Direct) |
View |
| 2022-11-04 Sale |
2022-11-08 6:19 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,493 | $4.54 | $15,858 | 616,017 (Direct) |
View |
| 2022-10-04 Sale |
2022-10-05 4:12 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,488 | $5.87 | $20,475 | 619,510 (Direct) |
View |
| 2022-09-08 Sale |
2022-09-09 08:17 am |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,479 | $5.2301 | $18,196 | 622,998 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-05 4:08 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
2,314 | $4.48 | $10,367 | 626,477 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-11 4:18 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
2,115 | $5.1762 | $10,948 | 628,791 (Direct) |
View |
| 2022-06-13 Sale |
2022-06-14 7:25 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer |
1,551 | $5.2062 | $8,075 | 89,949 (Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 5:20 pm |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
538,784 | $6.3751 | $3,434,798 | 16,673 (Indirect) |
View |
| 2022-06-07 Sale |
2022-06-08 4:23 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
2,542 | $5.7602 | $14,642 | 630,906 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-24 Option Award |
2023-05-25 4:11 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:10 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:09 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:08 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:06 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | Honig Peter Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:05 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-05-24 Option Award |
2023-05-25 4:04 pm |
N/A 2033-05-23 |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
34,000 | $0 | 34,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:39 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
100,000 | $0 | 165,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:38 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
95,000 | $0 | 159,131 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:36 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
60,000 | $0 | 128,313 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
70,000 | $0 | 146,122 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:33 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
100,000 | $0 | 210,687 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:30 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
95,000 | $0 | 245,361 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:28 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
252,000 | $0 | 823,622 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 9:03 pm |
N/A 2032-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
50,000 | $0 | 100,546 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 9:01 pm |
N/A 2032-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
50,000 | $0 | 113,000 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 9:00 pm |
N/A 2032-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
75,000 | $0 | 164,949 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 8:59 pm |
N/A 2032-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
75,000 | $0 | 213,509 (Direct) |
View |
Ownership |
2022-08-19 4:15 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
0 | $0 | 180,000 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 08:05 am |
N/A 2023-01-20 |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
7,576 | $0 | 13,606 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 08:05 am |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
7,576 | $1.485 | 13,606 (Direct) |
View |